Immunomodulatory drug maintenance therapy vs placebo/observation
Progression‐free survival · people with chronic lymphocytic leukaemia
Immunomodulatory drug maintenance therapy probably leads to lower progression‐free survival compared with placebo/observation (moderate certainty).
1 finding from 1 review
- HR 0.37 [0.19, 0.73]3 studies · 461 participantsModerate